Tscan Therapeutics Inc

XNAS: TCRX

Download real time

1.44 0.14 (10.77%)

85.14% Fall from 52W High

1.0M XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

81.5

Market Cap

Below industry Median

0.2

Beta 1Year

Very Low volatility

Tscan Therapeutics Inc - TCRX - stock price prediction, stock price target, analyst ratings from 8 analysts

Tscan Therapeutics Inc has a share price target of US$ 10, revenue growth forecast of 146.5%, and profit growth estimate of -14.8% for FY25, based on top 8 analyst calls.

Forecaster Screeners